Search results for "Personal genomics"

showing 2 items of 2 documents

openSNP–A Crowdsourced Web Resource for Personal Genomics

2014

Genome-Wide Association Studies are widely used to correlate phenotypic traits with genetic variants. These studies usually compare the genetic variation between two groups to single out certain Single Nucleotide Polymorphisms (SNPs) that are linked to a phenotypic variation in one of the groups. However, it is necessary to have a large enough sample size to find statistically significant correlations. Direct-To-Consumer (DTC) genetic testing can supply additional data: DTC-companies offer the analysis of a large amount of SNPs for an individual at low cost without the need to consult a physician or geneticist. Over 100,000 people have already been genotyped through Direct-To-Consumer genet…

GenotypeScienceInformation Storage and RetrievalBiological Data ManagementGenome-wide association studyGenomicsBiologySocial and Behavioral SciencesPolymorphism Single NucleotideFormal CommentGenomic MedicineGenome Analysis Toolsddc:570Genetic variationGenome-Wide Association StudiesGenome DatabasesGeneticsmedicineHumansGenetic TestingPrecision MedicineBiologyGenetic Association StudiesInformation ScienceGenetic testingGenetic associationClinical GeneticsGeneticsInternetMultidisciplinarymedicine.diagnostic_testInformation DisseminationQPersonalized MedicineRComputational BiologyHuman GeneticsGenomicsGeneticistData scienceOpen dataPhenotypeGenetics of DiseaseMedicineCrowdsourcingSoftwareResearch ArticleGenome-Wide Association StudyPersonal genomicsPLoS ONE
researchProduct

New landscapes and horizons in hepatocellular carcinoma therapy

2020

Hepatocellular carcinoma (HCC), is the sixth most frequent form of cancer and leads to the fourth highest number of deaths each year. HCC results from a combination of environmental factors and aging as there are driver mutations at oncogenes which occur during aging. Most of HCCs are diagnosed at advanced stage preventing curative therapies. Treatment in advanced stage is a challenging and pressing problem, and novel and well-tolerated therapies are urgently needed. We will discuss further advances beyond sorafenib that target additional signaling pathways and immune checkpoint proteins. The scenario of possible systemic therapies for patients with advanced HCC has changed dramatically in …

OncologySorafenibmedicine.medical_specialtySettore MED/09 - Medicina InternaCarcinoma Hepatocellularmedicine.medical_treatmentAntineoplastic AgentsReviewTargeted therapy03 medical and health sciences0302 clinical medicineInternal medicinemedicineBiomarkers TumorcancerHumansHCC030304 developmental biology0303 health sciencesbusiness.industryagingLiver NeoplasmsCancerCell BiologyImmunotherapyGenetic Therapymedicine.diseaseOmicstargeted therapyImmune checkpointdigestive system diseases3. Good healthGene Expression Regulation Neoplastic030220 oncology & carcinogenesisHepatocellular carcinomaimmunotherapybusinessmedicine.drugPersonal genomicsAging (Albany NY)
researchProduct